Biomerica, Inc.
BMRA
$2.38
-$0.02-0.63%
NASDAQ
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -20.05% | -11.31% | -1.88% | 5.05% | 1.40% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -20.05% | -11.31% | -1.88% | 5.05% | 1.40% |
| Cost of Revenue | -15.49% | -15.41% | 0.10% | 2.61% | 7.93% |
| Gross Profit | -58.12% | 31.13% | -17.60% | 23.99% | -32.62% |
| SG&A Expenses | -12.83% | -19.20% | -15.88% | -15.25% | -4.38% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.19% | -18.67% | -11.33% | -10.79% | -3.05% |
| Operating Income | 10.60% | 24.89% | 19.36% | 23.62% | 6.92% |
| Income Before Tax | 28.20% | 40.48% | 16.26% | 23.09% | 6.81% |
| Income Tax Expenses | -25.00% | -95.65% | -95.24% | -91.67% | -84.81% |
| Earnings from Continuing Operations | 28.19% | 40.68% | 16.81% | 23.61% | 7.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 28.19% | 40.68% | 16.81% | 23.61% | 7.83% |
| EBIT | 10.60% | 24.89% | 19.36% | 23.62% | 6.92% |
| EBITDA | 10.73% | 25.28% | 19.71% | 24.03% | 7.17% |
| EPS Basic | 38.37% | 44.45% | 20.70% | 26.44% | 14.24% |
| Normalized Basic EPS | 38.36% | 44.25% | 20.17% | 25.95% | 13.26% |
| EPS Diluted | 37.44% | 43.65% | 20.32% | 26.74% | 14.63% |
| Normalized Diluted EPS | 38.36% | 44.25% | 20.17% | 25.95% | 13.26% |
| Average Basic Shares Outstanding | 20.13% | 11.54% | 5.18% | 4.34% | 6.10% |
| Average Diluted Shares Outstanding | 20.13% | 11.54% | 5.18% | 4.34% | 6.10% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |